Journal of Medicinal Chemistry · 2013 · 67 citations · 39 references
MedicineNeurosciencePharmacologyMolecular NeuroscienceMolecular PharmacologyNeuropharmacologyCholinergic PharmacologyLigand BindingNeurotransmissionNeurotransmitter ReceptorsNicotine PharmacologySynaptic TransmissionCharge DistributionNicotine Receptor PharmacologyNicotinic Acetylcholine Receptor AgonismNicotinic Receptor PharmacologySynthetic Peptide AnalogsSynthetic Peptide CharacterizationToxin ModificationToxin-receptor Interactions
The α3β4 nAChRs are implicated in pain sensation in the PNS and addiction to nicotine in the CNS. We identified an α-4/6-conotoxin (CTx) TxID from Conus textile. The new toxin consists of 15 amino acid residues with two disulfide bonds. TxID was synthesized using solid phase methods, and the synthetic peptide was functionally tested on nAChRs heterologously expressed in Xenopus laevis oocytes. TxID blocked rat α3β4 nAChRs with a 12.5 nM IC50, which places it among the most potent α3β4 nAChR antagonists. TxID also blocked the closely related α6/α3β4 with a 94 nM IC50 but showed little activity on other nAChR subtypes. NMR analysis showed that two major structural isomers exist in solution, one of which adopts a regular α-CTx fold but with different surface charge distribution to other 4/6 family members. α-CTx TxID is a novel tool with which to probe the structure and function of α3β4 nAChRs.
39
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Christie D. Fowler, Qun Lu, Paul M. Johnson et al. · Nature · 2011 · 664 citations · Full text
Medicine, Neurobiology, Neuroscience +14